Skip to main content

Allogeneic HSCT for autoimmune disease: a shared decision.

Publication ,  Journal Article
Sullivan, KM; Sarantopoulos, S
Published in: Nat Rev Rheumatol
December 2019

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Nat Rev Rheumatol

DOI

EISSN

1759-4804

Publication Date

December 2019

Volume

15

Issue

12

Start / End Page

701 / 702

Location

United States

Related Subject Headings

  • Retrospective Studies
  • Humans
  • Hematopoietic Stem Cell Transplantation
  • Autoimmune Diseases
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sullivan, K. M., & Sarantopoulos, S. (2019). Allogeneic HSCT for autoimmune disease: a shared decision. Nat Rev Rheumatol, 15(12), 701–702. https://doi.org/10.1038/s41584-019-0306-7
Sullivan, Keith M., and Stefanie Sarantopoulos. “Allogeneic HSCT for autoimmune disease: a shared decision.Nat Rev Rheumatol 15, no. 12 (December 2019): 701–2. https://doi.org/10.1038/s41584-019-0306-7.
Sullivan KM, Sarantopoulos S. Allogeneic HSCT for autoimmune disease: a shared decision. Nat Rev Rheumatol. 2019 Dec;15(12):701–2.
Sullivan, Keith M., and Stefanie Sarantopoulos. “Allogeneic HSCT for autoimmune disease: a shared decision.Nat Rev Rheumatol, vol. 15, no. 12, Dec. 2019, pp. 701–02. Pubmed, doi:10.1038/s41584-019-0306-7.
Sullivan KM, Sarantopoulos S. Allogeneic HSCT for autoimmune disease: a shared decision. Nat Rev Rheumatol. 2019 Dec;15(12):701–702.

Published In

Nat Rev Rheumatol

DOI

EISSN

1759-4804

Publication Date

December 2019

Volume

15

Issue

12

Start / End Page

701 / 702

Location

United States

Related Subject Headings

  • Retrospective Studies
  • Humans
  • Hematopoietic Stem Cell Transplantation
  • Autoimmune Diseases
  • 3202 Clinical sciences
  • 1103 Clinical Sciences